Equine-specific therapeutic compositions and methods of use
AssigneeEquistem Technology, LLC
InventorsChristian Beaudry, Jaehyun Kim
Life of this patent
Estimating the term…
Abstract
Equine-specific therapeutic compositions comprising placental-derived materials and methods of use, and method of producing said equine-specific therapeutic compositions that is clear, safe, and physiologically and biologically active liquid injectable. The tissue processing protocols described herein include methods for processing and decontaminating the incoming placental tissue and fluid having coloration and contaminants to produce a clear amnion and amniotic fluid injectable product while preserving postbiotics, proteins, exosomes, biocomponents and maintaining their physiological and biological properties.
Claims19
A therapeutic composition comprising:
- a. a micronized allantoamnion membrane comprising allantoamnion specific postbiotics;
- and
- b. a carrier solution, wherein the carrier solution comprises amniotic fluid comprising amniotic fluid specific postbiotics.
A method of treating cancer in an individual, the method comprising administering to the individual in need thereof a therapeutic amount of equine-specific therapeutic composition comprising:
- a. an equine-specific micronized allantoamnion membrane comprising allantoamnion specific postbiotics;
- and
- b. a carrier solution, wherein the carrier solution comprises equine-specific amniotic fluid comprising amniotic specific postbiotics.
A method of producing an equine-specific therapeutic composition, the method comprising:
- a. obtaining an equine-specific allantoamnion membrane and equine-specific amniotic fluid;
- b. processing the equine-specific allantoamnion membrane and the equine-specific amniotic fluid;
- wherein processing the equine-specific allantoamnion membrane comprises decontaminating and micronizing the allantoamnion membrane and wherein processing the equine specific amniotic fluid comprises decontaminating the amniotic fluid;
- and
- c. resuspending the micronized allantoamnion membrane into a carrier solution comprising the processed amniotic fluid to produce the equine specific therapeutic composition.
Dependencies are inferred from the claim text.